In April 2025, McDermott once again hosted its annual European Health & Life Sciences Symposium at the Shangri-La hotel in Paris. Attended by some 300 delegates from across the industry, participants including investors,...more
5/19/2025
/ Artificial Intelligence ,
Biotechnology ,
Innovation ,
Investment ,
Investors ,
Life Sciences ,
Machine Learning ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Technology Sector ,
Venture Capital
In April 2025, we were proud to host the annual European Health & Life Sciences Symposium at the Shangri-La hotel in Paris. Attended by some 300 delegates from across the industry, participants including investors,...more
5/5/2025
/ Artificial Intelligence ,
Biologics ,
Biotechnology ,
Clinical Trials ,
Healthcare ,
Healthcare Reform ,
Innovative Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Technology Sector ,
Venture Capital
In November, McDermott Will & Emery was pleased to host our annual European Health & Life Sciences Symposium in Paris. Welcoming a large crowd of healthcare professionals, investors and dealmakers for a programme of...more
1/22/2024
/ Algorithms ,
Artificial Intelligence ,
Big Data ,
EU ,
Health Information Technologies ,
Healthcare ,
Investment Adviser ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Privacy Laws ,
Technology Sector
200+ leading individuals in healthcare, life sciences and private equity gathered at the Shangri-La Hotel in Paris for the European Health & Life Sciences Symposium 2023 to enjoy a day packed with fireside chats, in-depth...more
11/28/2023
/ Artificial Intelligence ,
Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Information Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
RUSSIA RESPONDS TO WESTERN SANCTIONS WITH PATENT RETALIATION -
On March 6, 2022, the Russian government retaliated against the West’s imposition of sanctions by issuing a decree permitting patented innovations to be used...more
6/27/2022
/ Appeals ,
Biotechnology ,
Cosmetics ,
Dietary Supplements ,
EU ,
France ,
Intellectual Property Protection ,
Medical Devices ,
Patent Litigation ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Russia ,
Sanctions ,
Trademark Litigation ,
Trademarks
Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments...more
6/1/2022
/ Anti-Kickback Statute ,
Artificial Intelligence ,
Cross-Border ,
Global Market ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Medical Technology Companies ,
Merger Controls ,
Pharmaceutical Industry ,
Technology Sector ,
Telemedicine
UNIFIED PATENT COURT -
The Unified Patent Court (UPC) should become a reality in 2022 or in the first few months of 2023.
The Protocol on Provisional Application (PPA) of the Agreement on a Unified Patent Court (AUPC)...more
2/21/2022
/ EU ,
France ,
Healthcare ,
Manufacturers ,
Medical Devices ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Trademarks ,
Unfair Competition
Patent and trademark issues effecting pharmaceutical laboratories, biotechs, food supplements and dietary products professionals, cosmetics companies and medical devices manufacturers is continually evolving across France and...more
9/29/2021
/ Counterfeiting ,
EU ,
France ,
Intellectual Property Protection ,
Inventions ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Revocation ,
Trademark Infringement ,
Trademark Invalidity ,
Trademarks
Companies frequently encounter challenges in the manufacture and supply of their innovative products, in particular with respect to process development and production capacity.
In our latest webinar, we review how key...more
3/17/2021
/ Biotechnology ,
Capacity ,
Intellectual Property Protection ,
Liability ,
Life Sciences ,
Manufacturers ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Supply Agreements ,
Warranties ,
Webinars